Zepbound outperforms Wegovy in head-to-head weight loss study
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy.
1 hour ago
0
0
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy.
1 hour ago
0
0
The first five years of a child's life may be key to preventing overweight and obesity in years to come, say the authors of new research being presented at this year's European Congress on Obesity (ECO 2025) held in Malaga, ...
30 minutes ago
0
0
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the journal eClinicalMedicine finds that first-generation weight-loss medications like liraglutide and ...
2 hours ago
0
11
Individuals who lived with obesity as children are less likely to be in work or studying in their mid-20s than their peers, new research presented at the European Congress on Obesity (ECO 2025) has found.
1 hour ago
0
0
Childhood overweight and obesity are a growing public health challenge in South Africa. In 2016, 13% of the country's children were reported to be obese. This is predicted to double by 2030.
1 hour ago
0
0
The UK is facing what charities are calling an eating disorder epidemic, with an estimated 1.25 million people affected. These conditions have the highest mortality rate of any mental health illness, making early intervention ...
2 hours ago
0
0